The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detection of FGFR fusions in intrahepatic cholangiocarcinoma using targeted RNA sequencing.
 
Maria Farooq
No Relationships to Disclose
 
Havell Markus
No Relationships to Disclose
 
Bradon McDonald
Patents, Royalties, Other Intellectual Property - Inventor on a patent application licensed to Exact Sciences Corporation related to the TARDIS ctDNA diagnostic assay.
 
Jan B. Egan
No Relationships to Disclose
 
Tania Contente-Cuomo
Employment - Translational Genomics Research Institute
 
Ahuva Odenheimer
No Relationships to Disclose
 
Martin Fernandez-Zapico
Consulting or Advisory Role - TYME; Varian Biopharma
 
Mitesh J. Borad
Stock and Other Ownership Interests - AVEO; Gilead Sciences; Intercept Pharmaceuticals; Spectrum Pharmaceuticals
Consulting or Advisory Role - Agios (Inst); ArQule (Inst); Celgene (Inst); De Novo Pharmaceuticals; Exelixis; Fujifilm (Inst); G1 Therapeutics; Genentech; Halozyme (Inst); Immunovative Therapies; Imvax; Inspyr Therapeutics; Insys Therapeutics (Inst); Klus Pharma; Lynx Group; Merck; Novartis (Inst); Pieris Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Western Oncolytics
Research Funding - Adaptimmune (Inst); Agios (Inst); ARIAD (Inst); Basilea (Inst); BiolineRx (Inst); Boston Biomedical (Inst); Celgene (Inst); Dicerna (Inst); Eisai (Inst); EMD Serono (Inst); Halozyme (Inst); ImClone Systems (Inst); Incyte (Inst); Incyte (Inst); Isis Pharmaceuticals (Inst); MedImmune (Inst); Merck Serono (Inst); miRNA Therapeutics (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); RedHill Biopharma (Inst); Senhwa Biosciences (Inst); Sillajen (Inst); Sun Biopharma (Inst); Taiho Pharmaceutical (Inst); Threshold Pharmaceuticals (Inst); Toray Industries (Inst)
Travel, Accommodations, Expenses - ArQule; AstraZeneca; Celgene
 
Muhammed Murtaza
Stock and Other Ownership Interests - PetDx
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - PetDx
Patents, Royalties, Other Intellectual Property - IP licensed to Exact Sciences; IP licensed to Inivata; Pending patent applications for diagnostic methods